Sigma Pharmaceuticals
From Wikipedia, the free encyclopedia
 |
This article relies on references to primary sources or sources affiliated with the subject, rather than references from independent authors and third-party publications. Please add citations from reliable sources. (December 2006) |
 |
|
| Type | Public (ASX:SIP) |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1912 in Melbourne, Australia |
| Headquarters | Rowville, Victoria, Australia |
| Area served | Worldwide |
| Key people | Brian Jamieson (Chairman) Mark Hooper (CEO & Managing Director) |
| Products | Prescription, Over-the-counter and Generic Pharmaceutical Products |
| Revenue | A$2.9 billion |
| Employees | 850 |
| Subsidiaries | Amcal Amcal Max Guardian Pharmacies |
| Website | sigmaco.com.au |
Sigma Pharmaceuticals Limited is a company which started in 1975 and is listed on the Australian Stock Exchange that produces over-the-counter drugs and prescription medicine. The company employes over 400 people.
[edit] 2010 trading halt
In 2010, Sigma shares were placed in a trading halt on the Australian Stock Exchange - initially due to a profit warning. Since then, allegations of accounting irregularities[1] and preferential deals negotiated with certain pharmacy chains (at the expense of smaller independent chemists) that left Sigma losing money at the expense of their own Amcal and Guardian Pharmacies banners[2] and forsaking cashflow have emerged[3]. The trading halt was lifted later that year.
[edit] References
[edit] External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 |
This article about an Australian corporation or company is a stub. You can help Wikipedia by expanding it. |
